HPHA

Heidelberg Pharma AG

  • Germany
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions EUR
FY21:
9.01
FY22:
87.9
FY23:
56.6
FY24:
47.6
FY25:
28.3
(positive)
Change from FY21 to FY25
millions EUR
FY21:
12.7
FY22:
12.7
FY23:
13.7
FY24:
13.2
FY25:
9.81
Total assets
Change from FY21 to FY25
millions EUR
FY21:
21.7
FY22:
101
FY23:
70.4
FY24:
60.7
FY25:
38.1

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions EUR
FY21:
14.9
FY22:
27.9
FY23:
19.8
FY24:
8.00
FY25:
11.2
(negative)
Change from FY21 to FY25
millions EUR
FY21:
0.10
FY22:
6.00
FY23:
1.24
FY24:
21.9
FY25:
37.8
(positive)
Change from FY21 to FY25
millions EUR
FY21:
6.70
FY22:
66.6
FY23:
49.3
FY24:
30.9
FY25:
−10.9
Total liabilities & equity
Change from FY21 to FY25
millions EUR
FY21:
21.7
FY22:
101
FY23:
70.4
FY24:
60.7
FY25:
38.1

All amounts in millions EUR Data source:Twelve Data